Haibo Han
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- RNA Research and Splicing
Papers in
-
- Cancer-related molecular mechanisms research 13
- MicroRNA in disease regulation 8
- Journals
- Oncotarget (3 papers)Cell Death and Disease (2 papers)Cell Death Discovery (1 paper)Nature Communications (1 paper)Cancer Communications (1 paper)
- Partner nations
- ChinaEthiopiaUnited States
In The Last Decade
Haibo Han
41 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 87
- Cancer Research 510
- Molecular Biology 735
- Oncology 262
- Cell Biology 75
- Hepatology 32
Countries citing papers authored by Haibo Han
This map shows the geographic impact of Haibo Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haibo Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haibo Han more than expected).
Fields of papers citing papers by Haibo Han
This network shows the impact of papers produced by Haibo Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haibo Han. The network helps show where Haibo Han may publish in the future.
Co-authors
The 25 scholars most cited alongside Haibo Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 11 | |
| 2 | 2023 | 14 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 7 | |
| 6 | 2021 | 28 | |
| 7 | 2021 | 8 | |
| 8 | 2021 | 10 | |
| 9 | 2021 | 26 | |
| 10 | 2020 | 27 | |
| 11 | 2020 | 30 | |
| 12 | The combination of circRNA-UMAD1 and Galectin-3 in peripheral circulation is a co-biomarker for predicting lymph node metastasis of thyroid carcinoma. | 2020 | 11 |
| 13 | 2019 | 37 | |
| 14 | 2018 | 12 | |
| 15 | 2018 | 10 | |
| 16 | 2017 | 9 | |
| 17 | 2017 | 20 | |
| 18 | 2015 | 63 | |
| 19 | 2013 | 133 | |
| 20 | 2013 | 165 |
About Haibo Han
Haibo Han is a scholar working on Cancer Research, Cell Biology, Oncology, Molecular Biology and Immunology, having authored 42 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (13 papers), MicroRNA in disease regulation (8 papers), RNA modifications and cancer (8 papers), Cancer Cells and Metastasis (7 papers), Circular RNAs in diseases (7 papers), Epigenetics and DNA Methylation (5 papers), RNA Research and Splicing (4 papers) and Ferroptosis and cancer prognosis (3 papers). The work is most often cited by research in Cancer Research (510 citations), Molecular Biology (735 citations), Oncology (262 citations), Cell Biology (75 citations) and Hepatology (32 citations). Haibo Han has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Zhiqian Zhang, Wei Zhao, Jinfeng Chen, Yuanyuan Ma, Yue Yang, Jianzhi Zhang, Baocai Xing, Jiafu Ji, Ting Guo and Fang Fang. Their work appears in journals such as Oncotarget, Cell Death and Disease, Cell Death Discovery, Nature Communications and Cancer Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.